Schedule 13G ownership disclosure

Upstream Bio Inc

Common Stock, par value $0.001 per share · CUSIP: 91678A107

Event date: 2024-12-31

Filing-level shares
2,715,056.00
Percent of class
5.1%
  • HBM Healthcare Investments (Cayman) Ltd.

    Shares: 2,715,056.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-012954
Form type
SCHEDULE 13G
Filer
HBM Healthcare Investments (Cayman) Ltd.
CIK
CIK 1232258
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub